Omgeo has partnered with Enfusion, a provider of hosted portfolio management solutions for hedge funds and alternative investment firms, to offer their clients a joint solution connecting Enfusions platform, Integrta, with Omgeo Central Trade Manager (CTM).
Omgeo CTM is a strategic platform for the central matching of domestic and cross-border exchange-traded derivatives (ETDs), contracts for difference, equities and fixed income transactions.
The Omgeo and Enfusion joint solution offers automated ETD post-trade processes for the global hedge fund industry and standardized post-trade workflows to enhance the STP of ETD trades.
Omgeo surveys of European and American hedge funds conducted within the last 12 months found that American hedge funds anticipated a 21% increase in their ETD trade volume, while European funds anticipated a 9.8% increase. Operational improvements across pre- and post-trade processes will continue to grow in importance as funds diversify their portfolios and volumes increase, according to the surveys.
Tarek Hammoud, managing partner at Enfusion, said: Our clients are moving toward more integrated workflows in post-trade operations, and many continue to express an interest in this new solution. Partnering with Omgeo is a logical step as it allows us to assist our clients to increase efficiencies in the processing of listed derivatives and reduce operational risks.
Ted Leveroni, executive director of derivative strategy and external relations at Omgeo, said: As hedge funds continue to boost their trading strategies with listed derivatives, they need to ensure their middle- and back-office processes keep pace with their front-office activities. This new joint offering highlights Omgeos aim to facilitate efficiency across the evolving global markets, increasing the use of best practice automation and lowering risk for buy- and sell-side firms alike.
(JDC)